AU6750587A – Opthlamic use of quinoline and naphthyridine antibiotics
– Google Patents
AU6750587A – Opthlamic use of quinoline and naphthyridine antibiotics
– Google Patents
Opthlamic use of quinoline and naphthyridine antibiotics
Info
Publication number
AU6750587A
AU6750587A
AU67505/87A
AU6750587A
AU6750587A
AU 6750587 A
AU6750587 A
AU 6750587A
AU 67505/87 A
AU67505/87 A
AU 67505/87A
AU 6750587 A
AU6750587 A
AU 6750587A
AU 6750587 A
AU6750587 A
AU 6750587A
Authority
AU
Australia
Prior art keywords
naphthyridine
antibiotics
opthlamic
quinoline
quinolone
Prior art date
1986-02-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU67505/87A
Other versions
AU588958B2
(en
Inventor
Carl L. Heifetz
Thomas F. Mich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1986-02-03
Filing date
1987-01-12
Publication date
1987-08-06
1987-01-12
Application filed by Warner Lambert Co LLC
filed
Critical
Warner Lambert Co LLC
1987-08-06
Publication of AU6750587A
publication
Critical
patent/AU6750587A/en
1989-09-28
Application granted
granted
Critical
1989-09-28
Publication of AU588958B2
publication
Critical
patent/AU588958B2/en
2007-01-12
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
A61K31/47—Quinolines; Isoquinolines
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/33—Heterocyclic compounds
A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P27/00—Drugs for disorders of the senses
A61P27/02—Ophthalmic agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/04—Antibacterial agents
Abstract
Quinolone and naphthyridine antibiotics useful for treating ocular infections by topical administration.
AU67505/87A
1986-02-03
1987-01-12
Opthlamic use of quinoline and naphthyridine antibiotics
Ceased
AU588958B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US825007
1986-02-03
US06/825,007
US4692454A
(en)
1986-02-03
1986-02-03
Opthalmic use of quinolone antibiotics
Publications (2)
Publication Number
Publication Date
AU6750587A
true
AU6750587A
(en)
1987-08-06
AU588958B2
AU588958B2
(en)
1989-09-28
Family
ID=25242879
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU67505/87A
Ceased
AU588958B2
(en)
1986-02-03
1987-01-12
Opthlamic use of quinoline and naphthyridine antibiotics
Country Status (14)
Country
Link
US
(2)
US4692454A
(en)
EP
(1)
EP0235589B1
(en)
JP
(1)
JPS62185085A
(en)
AT
(1)
ATE81776T1
(en)
AU
(1)
AU588958B2
(en)
CA
(1)
CA1281653C
(en)
DE
(1)
DE3782346T2
(en)
DK
(1)
DK173401B1
(en)
ES
(1)
ES2044843T3
(en)
GR
(1)
GR3006180T3
(en)
IE
(1)
IE61017B1
(en)
NZ
(1)
NZ219138A
(en)
PH
(2)
PH23722A
(en)
ZA
(1)
ZA87164B
(en)
Families Citing this family (19)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4826985A
(en)
*
1986-04-25
1989-05-02
Abbott Laboratories
Intermediates for preparation of racemate and optically active ofloxacin and related derivatives
US5229128A
(en)
*
1986-06-11
1993-07-20
Haddad Heskel M
Drug delivery ophthalmic insert and method of preparing same
WO1990011781A1
(en)
*
1989-04-04
1990-10-18
Alcon Laboratories, Inc.
The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions
WO1991009616A1
(en)
*
1989-12-22
1991-07-11
Yale University
Quinolone antibiotics encapsulated in lipid vesicles
US4992449A
(en)
*
1990-02-01
1991-02-12
American Cyanamid Company
7-(substituted)cycloalkylamino-1-(substituted)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
US5130353A
(en)
*
1990-03-07
1992-07-14
Ppg Industries, Inc.
Method for preparing photochromic plastic article
US5185390A
(en)
*
1990-03-07
1993-02-09
Ppg Industries, Inc.
Water strippable photochromic resin composition
JPH0725747B2
(en)
*
1990-03-16
1995-03-22
エスエス製薬株式会社
Quinolonecarboxylic acid derivative
US5252318A
(en)
*
1990-06-15
1993-10-12
Allergan, Inc.
Reversible gelation compositions and methods of use
CA2174803C
(en)
*
1996-04-23
2000-07-11
Jonathan P. Wong
Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug
US6861411B1
(en)
*
1997-12-02
2005-03-01
Pfizer, Inc.
Method of treating eye infections with azithromycin
US6685958B2
(en)
2001-04-25
2004-02-03
Insite Vision Incorporated
Quinolone carboxylic acid compositions and related methods of treatment
US6699492B2
(en)
*
1999-03-31
2004-03-02
Insite Vision Incorporated
Quinolone carboxylic acid compositions and related methods of treatment
US6239113B1
(en)
1999-03-31
2001-05-29
Insite Vision, Incorporated
Topical treatment or prevention of ocular infections
US7056893B2
(en)
*
1999-03-31
2006-06-06
Insite Vision, Inc.
Topical treatment for prevention of ocular infections
JP4756674B2
(en)
*
2000-09-05
2011-08-24
株式会社サクラクレパス
Applicator
US20060046970A1
(en)
*
2004-08-31
2006-03-02
Insite Vision Incorporated
Topical otic compositions and methods of topical treatment of prevention of otic infections
RU2010151994A
(en)
*
2008-05-19
2012-06-27
Алькон Рисерч, Лтд. (Us)
PHARMACEUTICAL COMPOSITIONS INCLUDING A CARBOXYVINYL POLYMER AND A POVIDONE POLYMER
WO2023205415A1
(en)
*
2022-04-22
2023-10-26
Mitobridge Inc.
Transcription factor eb activators and uses thereof
Family Cites Families (25)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US3963736A
(en)
*
1970-01-28
1976-06-15
Sumitomo Chemical Company, Limited
Preparation of 1-(lower alkyl)-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acids
US3907808A
(en)
*
1971-05-17
1975-09-23
Sterling Drug Inc
1,4-Dihydro-4-oxo-7-pyridyl-3-quinolinecarboxylic acid derivatives
US3753993A
(en)
*
1971-05-17
1973-08-21
Sterling Drug Inc
1,4-dihydro-4-oxo-7-pyridyl-3-quinoline-carboxylic acid derivatives
JPS53141286A
(en)
*
1977-05-16
1978-12-08
Kyorin Seiyaku Kk
Novel substituted quinolinecarboxylic acid
DE2808070A1
(en)
*
1978-02-24
1979-08-30
Bayer Ag
PROCESS FOR THE PRODUCTION OF 4-PYRIDONE-3-CARBONIC ACIDS AND / OR DERIVATIVES
JPS5845426B2
(en)
*
1978-09-29
1983-10-08
杏林製薬株式会社
Substituted quinoline carboxylic acid derivatives
JPS5649382A
(en)
*
1979-09-28
1981-05-02
Dainippon Pharmaceut Co Ltd
6-fluoro-7-cyclic amino-1,8-naphthylidine derivative and its salt
JPS5746986A
(en)
*
1980-09-02
1982-03-17
Dai Ichi Seiyaku Co Ltd
Pyrido(1,2,3-de)(1,4)benzoxazine derivative
DE3033157A1
(en)
*
1980-09-03
1982-04-01
Bayer Ag, 5090 Leverkusen
7-AMINO-1-CYCLOPROPYL-4-OXO-1,4-DIHYDRO-NAPHTHYRIDINE-3-CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE ANTIBACTERIAL AGENTS CONTAINING THEM
SE440354B
(en)
*
1981-02-19
1985-07-29
Kyorin Seiyaku Kk
quinolinecarboxylic
US4382937A
(en)
*
1981-02-27
1983-05-10
Dainippon Pharmaceutical Co., Ltd.
Naphthyridine derivatives and their use as anti-bacterials
JPS57145862A
(en)
*
1981-03-06
1982-09-09
Kyorin Pharmaceut Co Ltd
Quinolinecarboxylic acid derivative
US4499091A
(en)
*
1982-03-31
1985-02-12
Sterling Drug Inc.
1-Amino (or substituted amino)-1,4-dihydro-4-oxo-6-fluoro-7-heterylquinoline-3-carboxylic acids and their use as antibacterial agents
IE55898B1
(en)
*
1982-09-09
1991-02-14
Warner Lambert Co
Antibacterial agents
US4665079A
(en)
*
1984-02-17
1987-05-12
Warner-Lambert Company
Antibacterial agents
DE3318145A1
(en)
*
1983-05-18
1984-11-22
Bayer Ag, 5090 Leverkusen
7-AMINO-1-CYCLOPROPYL-6,8-DIFLUOR-1,4-DIHYDRO-4-OXO-3-CHINOLINE CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR CONTAINING ANTIBACTERIAL AGENTS
FR2559484B2
(en)
*
1983-07-06
1986-09-26
Provesan Sa
NEW DERIVATIVE 7- (PYRROL-1-YL) OF 1-ETHYL-1,4-DIHYDRO-4-OXO- (1,8-NAPHTYRIDIN) -3-CARBOXYLIC ACID, ITS PREPARATION AND ITS APPLICATION AS A MEDICAMENT
CS274601B2
(en)
*
1983-07-27
1991-09-15
Dainippon Pharmaceutical Co
Method of 1,8-naphthyridine derivative production
US4551456A
(en)
*
1983-11-14
1985-11-05
Merck & Co., Inc.
Ophthalmic use of norfloxacin and related antibiotics
US4604401A
(en)
*
1984-07-20
1986-08-05
Warner-Lambert Company
Antibacterial agents III
IN162769B
(en)
*
1984-11-13
1988-07-09
Kyorin Seiyaku Kk
JPH0670032B2
(en)
*
1984-11-22
1994-09-07
大日本製薬株式会社
Aminopyrrolidine derivative, its ester and its salt
AU578793B2
(en)
*
1985-02-15
1988-11-03
Dainippon Pharmaceutical Co. Ltd.
Novel 1,8-naphthyridine derivatives and processes for preparation thereof
JPH0635457B2
(en)
*
1985-06-28
1994-05-11
杏林製薬株式会社
Pyridonecarboxylic acid derivative and method for producing the same
JP2874664B2
(en)
*
1996-09-18
1999-03-24
日本電気株式会社
Page printer
1986
1986-02-03
US
US06/825,007
patent/US4692454A/en
not_active
Expired – Lifetime
1987
1987-01-05
CA
CA000526640A
patent/CA1281653C/en
not_active
Expired – Fee Related
1987-01-09
ZA
ZA870164A
patent/ZA87164B/en
unknown
1987-01-12
AU
AU67505/87A
patent/AU588958B2/en
not_active
Ceased
1987-01-29
IE
IE23787A
patent/IE61017B1/en
not_active
IP Right Cessation
1987-01-30
PH
PH34791A
patent/PH23722A/en
unknown
1987-02-02
ES
ES87101354T
patent/ES2044843T3/en
not_active
Expired – Lifetime
1987-02-02
DK
DK198700524A
patent/DK173401B1/en
not_active
IP Right Cessation
1987-02-02
AT
AT87101354T
patent/ATE81776T1/en
not_active
IP Right Cessation
1987-02-02
JP
JP62020634A
patent/JPS62185085A/en
active
Pending
1987-02-02
NZ
NZ219138A
patent/NZ219138A/en
unknown
1987-02-02
EP
EP87101354A
patent/EP0235589B1/en
not_active
Expired – Lifetime
1987-02-02
DE
DE8787101354T
patent/DE3782346T2/en
not_active
Expired – Fee Related
1987-06-17
US
US07/062,999
patent/US4851415A/en
not_active
Expired – Lifetime
1988
1988-08-17
PH
PH37421A
patent/PH25096A/en
unknown
1992
1992-11-05
GR
GR920402501T
patent/GR3006180T3/el
unknown
Also Published As
Publication number
Publication date
AU588958B2
(en)
1989-09-28
IE870237L
(en)
1987-08-03
US4851415A
(en)
1989-07-25
IE61017B1
(en)
1994-09-07
US4692454A
(en)
1987-09-08
DK52487A
(en)
1987-08-04
DK173401B1
(en)
2000-09-25
GR3006180T3
(en)
1993-06-21
PH25096A
(en)
1991-02-19
ATE81776T1
(en)
1992-11-15
DE3782346D1
(en)
1992-12-03
ES2044843T3
(en)
1994-01-16
ZA87164B
(en)
1988-07-11
DK52487D0
(en)
1987-02-02
PH23722A
(en)
1989-11-03
EP0235589B1
(en)
1992-10-28
EP0235589A2
(en)
1987-09-09
NZ219138A
(en)
1990-03-27
CA1281653C
(en)
1991-03-19
EP0235589A3
(en)
1989-12-13
DE3782346T2
(en)
1993-03-11
JPS62185085A
(en)
1987-08-13
Similar Documents
Publication
Publication Date
Title
AU588958B2
(en)
1989-09-28
Opthlamic use of quinoline and naphthyridine antibiotics
NZ227680A
(en)
1991-11-26
Quinoline and naphthyridine derivatives, intermediates and pharmaceutical compositions
EP0142426A3
(en)
1986-12-17
Ophthalmic formulation containing norfloxacin and related antibiotics
AU1467888A
(en)
1988-10-20
Agent for the prophylaxis and therapy of retroviral infections
IE863104L
(en)
1987-06-12
Quinolone derivatives
EP0266576A3
(en)
1989-03-22
1-tert-alkyl-substituted naphthyridine and quinoline carboxylic acids as antibacterial agents
AU600264B2
(en)
1990-08-09
Treatment of fungal infections
WO1986007359A3
(en)
1987-04-09
Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
AU7379587A
(en)
1987-12-10
Pharmaceutical formulation for the treatment of bacterial infections
FI942505A
(en)
1994-05-27
Antibacterial aemnen
Legal Events
Date
Code
Title
Description
2004-08-12
MK14
Patent ceased section 143(a) (annual fees not paid) or expired
